Sony Tuteja, PharmD, MS
Sees patients age 18 and up
Penn Medicine Provider

About me

  • Research Assistant Professor of Medicine (Translational Medicine and Human Genetics)

Insurance accepted

My Locations

Qualifications and experience

Treatments and Conditions

My research

Tuteja S, O'Brien WJ, Ferraro JP, Damrauer SM, Itani KMF, Voight BF, Teerlink CC, Lynch JA, DuVall SL, Strebel T, Kim MJ, Wilson MA, Barrett TW; Million Veteran Program. Drug-Gene Interactions and Clinical Outcomes After Vascular Surgery in the Million Veteran Program , JAMA Surg, 160: 2025,804-813


Tuteja S, Cayabyab MAS, Hoffecker G, Varughese LA, de Dieu Ndayishimiye J, Wittner VA, Wang X, Hatch R, Capozzi D, Harr M, Santani A, Hakonarson H, Watson D, Gabriel P, Doucette A, Massa R, Damjanov N, Reddy N, Oyer R, Teitelbaum UR. Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial , JCO Precis Oncol: 2025,e2500086. doi: 10.1200/PO-25-00086


Yang G, Alarcon C, Chanfreau C, Lee NH, Friedman P, Nutescu E, Tuck M, O'Brien T, Gong L, Klein TE, Chang KM, Tsao PS, Meltzer DO, Lynch JA; Million Veteran Program; Tuteja S, Perera MA. Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans , Clin Pharmacol Ther, 117(5): 2025,1313-1324


Chanfreau-Coffinier C, Friede KA, Plomondon ME, Lee KM, Lu Z, Dinatale T, DuVall SL, Vassy JL, Waldo SW, Cleator JH, Maddox TM, Rader DJ, Assimes TL, Damrauer SM, Tsao PS, Chang KM, Voora D, Lynch JA, Giri J; VA Million Veteran Program; Tuteja S. CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program , Clin Pharmacol Ther, 118(4): 2025,876-884


Ho TT, Smith DM, Aquilante CL, Cicali EJ, El Rouby N, Hertz DL, Imanirad I, Patel JN, Scott SA, Swain SM, Tuteja S, Hicks JK; Pharmacogenomics Global Research Network Publication Committee. A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice , Clin Pharmacol Ther, 117(5): 2025,1194-1208


Stevenson JM, Smith DM, Tuteja S, Patel JN; Pharmacogenomics Global Research Network (PGRN) Publications Committee. Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test , Clin Pharmacol Ther, 118(3): 2025,561-566


Hoffecker G, Mulugeta-Gordon L, Wittner V, Wang X, Gysler S, Deagostino-Kelly M, Tuteja S. Feasibility of pharmacogenetic-guided selection of postoperative analgesics in gynecologic surgery patients: a prospective, randomized, pilot study , Pharmacogenet Genomics, 35: 2025,183-191


Pereira NL, Cresci S, Angiolillo DJ, Batchelor W, Capers Q 4th, Cavallari LH, Leifer D, Luzum JA, Roden DM, Stellos K, Turrise SL, Tuteja S; American Heart Association Professional/Public Education and Publications Committee of the Council on Genomic and Precision Medicine; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Peripheral Vascular Disease; and Stroke Council. CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association , Circulation, 150: 2024,e129-e150


Oni-Orisan A, Tuteja S, Hoffecker G, Smith DM, Castrichini M, Crews KR, Murphy WA, Nguyen NHK, Huang Y, Lteif C, Friede KA, Tantisira K, Aminkeng F, Voora D, Cavallari LH, Whirl-Carrillo M, Duarte JD, Luzum JA; Pharmacogenomics Global Research Network (PGRN) Publications Committee. An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers , Clin Pharmacol Ther, 114(2): 2023,275-287


Hoffecker G, Varughese LA, Bleznuck J, Landgraf J, Wollack C, Chen J, Ritchie MD, Nathanson KL, Tuteja S Customizing the electronic health record for delivery of pharmacogenetics. , Genetics in Medicine Open: 2023


View all publications